Arthrosamid is a non-biodegradable hydrogel used for the treatment of symptomatic
osteoarthritis of the knee.
Once injected into the intra-articular cavity of the knee joint, Arthrosamid integrates
into the synovial tissue to provide long-lasting cushioning of the inner joint,
reducing pain and decreasing joint stiffness. Following the completion of a three-month
prospective open label study, which demonstrated significant pain reduction in patients
with osteoarthritis of the knee, Arthrosamid received European approval in 2020.